MOAVERO, ROMINA
 Distribuzione geografica
Continente #
NA - Nord America 18.090
EU - Europa 1.316
AS - Asia 1.042
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 20.467
Nazione #
US - Stati Uniti d'America 18.080
SG - Singapore 664
IE - Irlanda 240
IT - Italia 221
UA - Ucraina 215
DE - Germania 174
CN - Cina 146
KR - Corea 128
RU - Federazione Russa 124
GB - Regno Unito 93
FR - Francia 78
FI - Finlandia 62
NL - Olanda 37
TW - Taiwan 34
PL - Polonia 33
JP - Giappone 21
ID - Indonesia 14
SE - Svezia 14
BR - Brasile 8
CA - Canada 7
CZ - Repubblica Ceca 7
IN - India 6
EU - Europa 5
HK - Hong Kong 5
VN - Vietnam 5
TR - Turchia 4
ES - Italia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BE - Belgio 2
CH - Svizzera 2
IR - Iran 2
LB - Libano 2
LK - Sri Lanka 2
MX - Messico 2
MY - Malesia 2
NO - Norvegia 2
PE - Perù 2
RO - Romania 2
SA - Arabia Saudita 2
SM - San Marino 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
GR - Grecia 1
LT - Lituania 1
MO - Macao, regione amministrativa speciale della Cina 1
PH - Filippine 1
PT - Portogallo 1
Totale 20.467
Città #
Woodbridge 5.448
Wilmington 4.799
Houston 3.878
Fairfield 762
Singapore 581
Ann Arbor 415
Chandler 323
Seattle 312
Ashburn 305
Cambridge 239
Dublin 229
Jacksonville 184
Medford 179
Santa Clara 125
Rome 99
Dearborn 98
Lawrence 89
Beijing 64
New York 60
Menlo Park 40
Norwalk 36
Kraków 33
Taipei 33
San Diego 32
Council Bluffs 20
London 20
Milan 19
Moscow 16
Mülheim 16
Jakarta 14
Redwood City 13
Del Norte 11
Lappeenranta 11
Redmond 8
Seoul 8
University Center 8
Brno 7
Falls Church 7
Hefei 7
Mountain View 7
Saint Petersburg 7
Salt Lake City 7
Shanghai 7
Amsterdam 6
Boardman 6
Nanjing 6
Turin 6
Verona 6
Zhengzhou 6
Frankfurt am Main 5
Helsinki 5
Jinan 5
Kunming 5
San Mateo 5
Chiswick 4
Dongguan 4
Dronten 4
Guangzhou 4
Nuremberg 4
Phoenix 4
Prescot 4
University Park 4
Aizu-wakamatsu Shi 3
Catania 3
Cernay 3
Chiyoda-ku 3
Fleet 3
Hanoi 3
Indiana 3
Istanbul 3
Kilburn 3
Los Angeles 3
Ottawa 3
Ribeirão Preto 3
São Paulo 3
Tokyo 3
Beirut 2
Chengdu 2
Colombo 2
Domagnano 2
Dong Ket 2
Fuzhou 2
Hangzhou 2
Hounslow 2
Hyderabad 2
Kuala Lumpur 2
Lima 2
Lugo 2
Mercer Island 2
Mondovì 2
Munich 2
Nanchang 2
Navi Mumbai 2
New Bedfont 2
Nürnberg 2
Palermo 2
Paris 2
Parma 2
Qualiano 2
Raleigh 2
Totale 18.759
Nome #
Current role of perampanel in pediatric epilepsy 486
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions 433
Neurological and neuropsychiatric aspects of tuberous sclerosis complex. 430
Cognitive development in females with PCDH19 gene-related epilepsy 426
mTOR Inhibitors in Tuberous Sclerosis Complex. 419
Peri-ictal water drinking: a rare automatic behaviour in temporal lobe epilepsy 404
Genotype/Phenotype Correlations in Tuberous Sclerosis Complex. 400
Mammalian Target of Rapamycin Inhibitors and Life-Threatening Conditions in Tuberous Sclerosis Complex. 395
Current role of melatonin in pediatric neurology: Clinical recommendations 394
Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders. 392
Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC 391
Reduction in retinal nerve fiber layer thickness in tuberous sclerosis complex. 386
Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis 384
Is mTOR inhibition a systemic treatment for tuberous sclerosis? 383
Long-term follow-up in children with benign convulsions associated with gastroenteritis 374
Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor 372
Abnormal parieto-motor connectivity in Tuberous Sclerosis Complex 365
Clinical Reasoning: A girl presenting with stiffness episodes during sleep, café-au-lait spots, and flecked retina 365
Headache and attention deficit and hyperactivity disorder in children: common condition with complex relation and disabling consequences 361
Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (TSC2) mutation 360
Combined targeted treatment in early onset epilepsy associated with tuberous sclerosis 360
Syndromic autism: Causes and pathogenetic pathways 359
Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy 358
The neurobiology of attention deficit/hyperactivity disorder. 354
The Challenge of Pharmacotherapy in Children and Adolescents with Epilepsy-ADHD Comorbidity 350
White matter disruption is associated with persistent seizures in tuberous sclerosis complex 349
Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex 349
Everolimus Alleviates Obstructive Hydrocephalus due to Subependymal Giant Cell Astrocytomas 345
Ketogenic diet in early myoclonic encephalopathy due to non ketotic hyperglycinemia 344
Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment. 343
Tubers, epileptogenic foci, and epileptogenic networks in tuberous sclerosis. 342
Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines 341
Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: The first Italian prospective study 336
MTOR inhibitors as a new therapeutic option for epilepsy 334
Paediatric use of melatonin (Author reply to D. J. Kennaway). 334
Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges. 333
Attention deficit hyperactivity disorder in children with epilepsy. 332
Early control of seizures improves long-term outcome in children with tuberous sclerosis complex. 323
The neurobiological basis of ADHD. 323
Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis. 318
The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective 318
Can we change the course of epilepsy in tuberous sclerosis complex? 298
Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations. 298
Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations 297
Syndrome of Transient Headache and Neurologic Deficits With Cerebrospinal Fluid Lymphocitosis Should Be Considered in Children Presenting With Acute Confusional State 296
New perspectives in Autism spectrum disorder associated with tuberous sclerosis 279
Vagus nerve stimulation for refractory epilepsy in tuberous sclerosis. 276
Pharmacotherapy of idiopathic generalized epilepsies 270
Neuroimaging findings of Sturge-Weber Syndrome in a child with Tuberous Sclerosis 263
Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy 254
Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations 252
Recent advances in neurobiology of Tuberous Sclerosis Complex 239
A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND) 186
mTOR dysregulation and tuberous sclerosis-related epilepsy 156
Everolimus for Retinal Astrocytic Hamartomas in Tuberous Sclerosis Complex 137
A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: A Delphi consensus report 127
Early Clinical Predictors of Autism Spectrum Disorder in Infants with Tuberous Sclerosis Complex: Results from the EPISTOP Study 123
Cyclic vomiting syndrome and benign paroxysmal torticollis are associated with a high risk of developing primary headache: A longitudinal study 117
Clinical Features of Pediatric Idiopathic Intracranial Hypertension and Applicability of New ICHD-3 Criteria 116
Immediate and prolonged-release melatonin in children with neurodevelopmental disabilities. Author reply to Prof. Zisapel 113
Features of primary chronic headache in children and adolescents and validity of ICHD 3 criteria 110
Prophylactic treatment of pediatric migraine: Is there anything new in the last decade? 108
Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations 99
Tolerability of palmitoylethanolamide in a pediatric population suffering from migraine: a pilot study 89
Is autism driven by epilepsy in infants with Tuberous Sclerosis Complex? 77
Anxiety, Depression, and Body Weight in Children and Adolescents With Migraine 56
Benign Intracranial Hypertension Due to Hypoparathyroidism: A Case Report 49
Sleep Disorders in Pediatric Migraine: A Questionnaire-Based Study 46
Case Report: Migralepsy: The Two-Faced Janus of Neurology 43
Sleep disorders and neuropsychiatric disorders in a pediatric sample of tuberous sclerosis complex: a questionnaire-based study 41
Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review 38
I stay at home with headache. A survey to investigate how the lockdown for COVID-19 impacted on headache in Italian children 38
High Intellectual Potential and High Functioning Autism: Clinical and Neurophysiological Features in a Pediatric Sample 36
null 35
null 35
Subacute Sclerosing Panencephalitis in Children: The Archetype of Non-Vaccination 33
Event-Related Potentials in ADHD Associated With Tuberous Sclerosis Complex: A Possible Biomarker of Symptoms Severity? 33
Neuropsychological Sequelae, Quality of Life and Adaptive Behavior in Children and Adolescents with Anti-NMDAR Encephalitis: A Narrative Review 31
Screen exposure and sleep: How the COVID-19 pandemic influenced children and adolescents - A questionnaire-based study 29
Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience 28
Long-Term Effects of COVID-19 Pandemic on Migraine in Adolescents. A Retrospective Analysis of the Population Attending the Headache Center in Different Phases of the Pandemic 28
Primary Headaches and Sleep Disorders: Review of Literature about Comorbidity in Children and Adolescents 28
null 28
Truths and Myths in Pediatric Migraine and Nutrition 26
How to Assess the Headache—Sleep Disorders Comorbidity in Children and Adolescents 26
Surgery for drug-resistant tuberous sclerosis complex-associated epilepsy: who, when, and what 26
Questionnaire-based assessment of sleep disorders in an adult population of Tuberous Sclerosis Complex 25
null 25
Restless sleep disorder in a sample of children and adolescents with autism spectrum disorder: preliminary results from a case series 23
Case report: A pediatric case of Bickerstaff brainstem encephalitis after COVID-19 vaccination and Mycoplasma pneumoniae infection: Looking for the culprit 23
Medication Overuse Withdrawal in Children and Adolescents Does Not Always Improve Headache: A Cross-Sectional Study 23
Features and Management of New Daily Persistent Headache in Developmental-Age Patients 23
Sleep disturbances and behavioral symptoms in pediatric Sotos syndrome 22
Long-term use of {mTORC}1 inhibitors in tuberous sclerosis complex associated neurological aspects 22
Migraine and Its Equivalents: What Do They Share? A Narrative Review on Common Pathophysiological Patterns 21
Interictal Cognitive Performance in Children and Adolescents With Primary Headache: A Narrative Review 19
Genetic pathogenesis of the epileptogenic lesions in Tuberous Sclerosis Complex: Therapeutic targeting of the mTOR pathway 18
Use of Nutraceutical Ingredient Combinations in the Management of Tension-Type Headaches with or without Sleep Disorders 17
Molecular EPISTOP, a comprehensive multi-omic analysis of blood from Tuberous Sclerosis Complex infants age birth to two years 17
Prediction of Neurodevelopment in Infants With Tuberous Sclerosis Complex Using Early EEG Characteristics 16
Totale 20.672
Categoria #
all - tutte 49.781
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.781


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.931 0 0 0 0 0 510 407 449 440 386 358 381
2020/20213.243 348 394 391 419 273 402 400 283 68 89 142 34
2021/2022741 33 54 28 10 22 62 26 21 159 54 54 218
2022/2023867 97 90 18 82 82 236 88 36 69 3 41 25
2023/2024418 43 9 21 3 28 97 8 3 3 17 98 88
2024/20251.383 57 672 359 155 83 57 0 0 0 0 0 0
Totale 20.791